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ABSTRACT
Real-time quantitative PCR (qPCR) is a powerful tool
for quantifying specific DNA target sequences.
Although determination of relative quantity is widely
accepted as a reliable means of measuring differen-
ces between samples, there are advantages to being
able to determine the absolute copy numbers of a
given target. One approach to absolute quantifica-
tion relies on construction of an accurate standard
curve using appropriate external standards of
known concentration. We have validated the use
of tissue genomic DNA as a universal external
standard to facilitate quantification of any target
sequence contained in the genome of a given spe-
cies, addressing several key technical issues
regarding its use. This approach was applied to
validate mRNA expression of gene candidates
identified from microarray data and to determine
gene copies in transgenic mice. A simple method
that can assist achieving absolute quantification of
gene expression would broadly enhance the uses
of real-time qPCR and in particular, augment the
evaluation of global gene expression studies.
INTRODUCTION
The continued improvement of methodologies for examining
gene expression is essential to further our understanding of
how the information contained within a genome is utilized
by the cellular machinery. The focus in recent years has
been on the development of techniques that allow the analysis
of the expression of a large number of genes simultaneously,
with the goal being to proﬁle the global expression under a
particular set of conditions. Equally important though is the
reﬁnement of techniques to more accurately quantify the
level of gene expression, with the goal being to determine
the absolute copy number of an expressed sequence.
The most traditional method for characterizing mRNA
transcripts is northern blot analysis. While this technique is
effective for sizing mature mRNA transcripts and identifying
alternatively spliced forms, quantiﬁcation is always relative
to a reference gene. RNase protection and S1 nuclease map-
ping assays are potentially more amenable to modiﬁcations
that would allow determination of absolute quantity but they
are not typically applied in this way. Furthermore, these tech-
niques are not easily scaleable for assessing the expression of
a large number of genes in many samples.
Approaches to global expression proﬁling include hybridi-
zation to various DNA microarray platforms and serial analy-
sis of gene expression (SAGE). In practice, these methods
rely on analysis of differential gene expression by measure-
ment of fold changes over a suitable control or baseline.
There has not been an extensive focus on using these global
mRNA proﬁling techniques for determining absolute quanti-
ties of expressed genes nor has it been determined whether
the current technologies are capable of measuring the concen-
tration or absolute copy number of a given expressed gene
sequence in an unknown sample with reasonable accuracy.
Cross-platform validation and conﬁrmation of ratiometric dif-
ferences in mRNA expression for selected genes are often
sufﬁcient for the biological objectives of many studies. How-
ever, the lack of robust and scaleable methods of absolute
gene copy quantiﬁcation not only represents an obvious deﬁ-
ciency in a most fundamental aspect of scientiﬁc measure-
ment, but also hinders the ability to study basic questions
concerning the accuracy and sensitivity of current genome-
scale mRNA proﬁling techniques.
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doi:10.1093/nar/gkl400Real-time PCR represents an innovative evolution of
conventional PCR that has emerged as a major analytical
platform in molecular biology. Incorporation of ﬂuorescence-
based detection systems into real-time PCR instruments
not only allows kinetic detection of the accumulation of
PCR products over the cycling period, but also provides
greater sensitivity for amplicon detection as compared to
conventional gel-based detection. Major uses of real-time
PCR include analysis of differential mRNA expression
(1–3) and SNP detection (4) although additional applications
have been described, including splice variant discrimination
(5,6), pathogen load diagnosis (7–9), cancer marker quantiﬁ-
cation (10–12) and genotyping (13,14).
In real-time PCR, the cycle at which the amount of detect-
able PCR product reaches a preset threshold level is assessed
(Ct). Relative quantities can be determined by normalizing
against the Ct value for an internal reference gene prior to
calculation of ratiometric differences between unknown
samples. Several mathematical formulas that calculate
relative fold changes have been proposed: 2 DDCt (15),
E
DCtðtargetÞ
target =E
DCtðcontrolÞ
control (16) and ð1 EÞ
 DDCt (17), in which
E represents ampliﬁcation efﬁciency. In contrast, the determi-
nation of absolute quantity of gene copy using real-time PCR
requires the generation of a standard curve from known quan-
tities of the PCR target sequence (18–21). Absolute quantiﬁ-
cation to measure copy number of a particular mRNA target
originally present in live cells or tissue remains technically
difﬁcult due to the lack of methodology that can comprehen-
sively account for all the variation that can occur during
cDNA sample preparation. However, the quantity of target
sequence in cDNA samples can be assessed with reasonable
accuracy using a proper external standard. A variety of mate-
rials have been used as external standards, including plasmid
DNA containing the target sequence (2,5,7,8,11,21), reverse-
transcribed cRNAs (3,6,22), PCR-ampliﬁed target sequences
(1,12,23) and commercially prepared DNA (9). Each has
advantages and disadvantages in terms of complexity of the
material, cost, accessibility, long-term stability and gene
copy accuracy.
In this study, we present a simple method using standard
curves generated from tissue genomic DNA (gDNA) that
enable quantiﬁcation of any naturally occurring gene
sequence in cDNA samples. We have characterized para-
meters with which gDNA can be used effectively as a uni-
versal standard curve. This methodology was applied to
validation of microarray data and genotyping of transgenic
mice to demonstrate quantiﬁcation of cDNA and gDNA,
respectively.
MATERIALS AND METHODS
Plasmid dilution and calculation of plasmid
copy numbers
Unless the copy numbers are speciﬁed, all green ﬂuorescent
protein (GFP) plasmid (4700 bp) standards were constructed
with a 3-fold dilution series ranging from 8100 to 100 copies.
The copy numbers of the GFP plasmid and PRKR plasmid
(5547 bp) are calculated based on the following formula
(http://www.appliedbiosystems.com/support/tutorials/pdf/
quant_pcr.pdf), in which n is the number of base pairs, m is
the mass of the DNA, NA is Avogadro’s number (6.02 · 10
23
bp/mol) and M is the average molecular weight of a base pair
(610 g/mol).
n ¼ð m · NAÞ/M
m ¼ n · 1:096 · 10 21 g/bp
Primer design and selection
All primers were designed with Primer Express (PE Applied
Biosystems, Perkin Elmer, Foster City, CA) based on target
sequences obtained from the Affymetrix database (NetAffx 
Analysis Center, http://www.affymetrix.com/analysis) for
each gene of interest. Primers were designed to target the
30-untranslated region (30-UTR) of transcript sequences
except GFP, HsPRKR P1, HsPRKR P2 and HsPRKR P3,
all of which target upstream exons. We ensured that the
primer pair will speciﬁcally amplify the target sequence by
searching for the nucleotide sequences that contain both pri-
mer sequences on opposing strands in the NCBI Genbank
database using BLAST (http://www.ncbi.nlm.nih.gov/
BLAST). Primer pairs were discarded if the alignment of
both primer sequences could result in the ampliﬁcation of
non-speciﬁc sequences. All new primers were tested by
real-time PCR using a 3-fold serial dilution (9–0.111 ng/
reaction) of gDNA and water as non-template control fol-
lowed by gel electrophoresis, in order to determine ampliﬁca-
tion efﬁciency, speciﬁcity and the presence/absence of primer
dimers. The ampliﬁcation efﬁciency for each primer was
determined from the linear slope of standard curve; only pri-
mers with a standard curve slope between  2.92 and  3.92
were used for further quantiﬁcation. Inefﬁcient and/or non-
speciﬁc primers were excluded. Lastly, Veriﬁcation of
Amplicon Speciﬁcity using Restriction Enzymes (VASRE,
see below) was performed to validate the sequence speciﬁcity
of the expected amplicons. A supplementary table contains
all the sequences of primers used in this paper (Online
Supplementary Table).
Extraction of RNA and gDNA
RNA extraction was performed according to the manufac-
turer’s manual for the RNeasy Kit (Qiagen). Both human
and mouse gDNA from various tissues (human tonsil, liver,
subcarinal lymph nodes and lung; mouse liver) was isolated
according to the manufacturer’s manual for the DNeasy Kit
(Qiagen). Mouse-tail gDNA was isolated by phenol extrac-
tion after overnight proteinase K digestion, and then DNA
is subsequently precipitated with ethanol and resuspended
in 10 mM Tris, 1 mM EDTA, pH 7.4. For the generation
of external standards, gDNA was stored as a 9 ng/ml stock
at  20 C, and a fresh 3-fold serial dilution was prepared
for each real-time PCR experiment (9–0.111 ng/reaction).
RT reaction and real-time PCR
DNase treatment was performed on RNA samples using
DNA-free (Ambion Inc.) according to the manufacturer’s
manual in order to remove gDNA carry-over. In a single
RT reaction, 5 mg of RNA was mixed with RNase-free
water (Qiagen) and 1 ml of oligo(dT23) (Sigma–Aldrich Co.)
to a ﬁnal volume of 12 ml, then incubated at 90 C for 10 min.
To this, 4 mlo f5 · First-Strand buffer, 2 ml of 0.1 M DTT,
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(Invitrogen Co.) were added. The mixture was incubated
at 42 C for 90 min followed by an extension period for
15 min at 70 C.
Real-time PCRs were performed using the ABI Prism
7900HT (PE Applied Biosystems) in 384 micro-well plates.
All samples, including the external standards and non-
template control, were run in triplicate. The reaction condi-
tions had been established through a series of preliminary
optimization experiments. Each 10 ml reaction contained 1·
PCR buffer (Sigma–Aldrich Co.), 3 mM MgCl2, 0.2 mM
dNTP, 1 nM forward and reverse primers, 1/50 dilution of
ROX reference dye (Sigma–Aldrich Co.), 3/100 000 dilution
of SYBR Green I (Sigma–Aldrich Co.), 0.05 U of JumpStart
Taq polymerase (Sigma–Aldrich Co.) and template DNA.
Template was either a 3-fold serial dilution (9–0.111 ng/
reaction) of gDNA for generation of a standard curve,
water for a non-template control which was included to con-
ﬁrm the absence of DNA contamination in the reaction
mixture, 10 ng of cDNA generated from total RNA or 1 ng
of cDNA generated from mRNA. The reaction was initiated
by activation of Taq polymerase at 95 C for 3 min, followed
by 40 three-step ampliﬁcation cycles consisting of 10 s dena-
turation at 95 C, 15 s annealing at 65 C and 20 s extension at
72 C. A ﬁnal dissociation stage was run to generate a melting
curve for veriﬁcation of ampliﬁcation product speciﬁcity.
Real-time PCR was monitored and analyzed by the Sequence
Detection System version 2.0 (PE Applied Biosystems).
Verification of amplicon specificity using
restriction enzymes
Our VASRE system used a panel of six restriction enzymes
(HpyCH4V, HaeIII, HinP1I, HpyCH4IV, MspI and RsaI,
all from New England Biolabs) to validate the sequence
speciﬁcity of the amplicons produced by real-time PCR pri-
mer pairs. The PCR products produced during real-time
PCR screening of new primer pairs were digested with each
enzyme in a separate reaction. Each VASRE reaction con-
tained 0.5 U of restriction enzyme, 1· of appropriate diges-
tion buffer, 0.8 ml of 25 mM MgCl2, 0.3 ml of SYBR
Green I 1/1000 dilution (Sigma–Aldrich Co.), 0.1 mlo f
ROX reference dye (Sigma–Aldrich Co.) and 1 ml of cDNA
template taken from a 9 ng gDNA standard originally
screened in real-time PCR to a ﬁnal volume of 10 ml, and
then incubated at 37 C for 1 h. The reaction mixture was
returned to a clean PCR plate, and a dissociation curve was
produced by measuring the peak ﬂuorescence change as the
temperature was increased. The dissociation curve after
digestion with each restriction enzyme was compared to the
dissociation curve generated after incubation of the PCR
product in the absence of enzyme.
Microarray
RT reactions for microarray were carried out as described
above, except that T7 oligo(dT) primer (Affymetrix, Inc.)
was used instead of oligo(dT23) (Sigma–Aldrich Co.). Micro-
array hybridizations were performed using the Affymetrix
HU133A chip (Affymetrix, Inc.) according to the user
manual. The array data were analyzed with Microarray
Suite ver. 5.0 (Affymetrix, Inc.).
RESULTS
Calculation of gene copy number in gDNA
Absolute quantiﬁcation by real-time PCR requires ampliﬁca-
tion of the target sequence from a series of external standards
of known quantities to generate a standard curve from which
the quantity of the target sequence in the unknown sample
can be calculated (18–21). Since all gene sequences for a
given species are represented, gDNA could serve as a univer-
sal standard for the absolute quantiﬁcation of any expressed
gene. The mass of the haploid human genome (C-value) is
 3.5 pg (http://www.genomesize.com), and therefore 1 ng
of gDNA contains  286 copies of a single-copy gene. Gen-
eration of standard curves ranging up to 10000 copies would
therefore require <35 ng of gDNA. We typically generate a
standard curve using a 3-fold dilution series to produce ﬁve
quantities ranging from 9 ng ( 2574 copies) to 0.111 ng
( 31 copies) of gDNA isolated from tonsils as a source of
normal diploid cells. A typical standard curve is shown in
Figure 1 generated from primers designed against the
human CCL2 gene. The Ct values range between cycles 23
and 30 (threshold ¼ 0.20), producing a standard curve with
a slope of  3.33 (R
2 ¼ 0.999).
Considerations for the design and testing of
gene-specific primers to generate a gDNA-based
standard curve
An essential consideration for using gDNA as an external
standard in real-time PCR is designing target-speciﬁc primer
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Figure 1. (A) A typical standard curve of Ct versus log copy number. The
points comprising the line are labeled with the copy number. (B) Ct values are
obtained from amplification plots which indicate the change in normalized
signal for the five standards (indicated with copy numbers) between cycles
20 and 40 of the PCR. Ct is the cycle at which fluorescence crosses a
threshold value.
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design intron-spanning primer pairs to mitigate signals
arising from contamination of RNA samples with gDNA,
we routinely treat samples with DNase to avoid this non-
speciﬁc ampliﬁcation.
Primer pairs designed against a gene of interest were
experimentally tested by generating a standard curve with
tissue-derived gDNA. Acceptable primers meet the following
criteria for efﬁciency and speciﬁcity.
(i) High amplification efficiency: Efficiency of amplification
can be determined by
E% ¼

10ð 1/slopeÞ   1

· 100%‚
using the slope from a standard curve plot (Ct versus log
copy number). Efficiency (100%) is therefore defined
by a slope of  3.32. We typically utilize primer pairs
that produce standard curves with slopes between  2.92
and  3.92 (Efficiency ¼ 100 ± 20%).
(ii) Specificity
(a) Dissociation plots are generated at the end of the
qPCR by slowly increasing the reaction temperature
and measuring the rate of decrease in fluorescence as
the strands of the final product separate. The
dissociation plot should consist of a single peak to
indicate a single product, and the peak of the curve
should occur at the expected melting temperature of
the amplicon.
(b) Specific amplification can be further verified by
assessing the size of the PCR product by agarose gel
electrophoresis.
(c) Verification of the Amplicon Specificity using
Restriction Enzymes (VASRE). We have developed
the VASRE assay to examine the dissociation curve
after digestion of the PCR products with a panel of
restriction enzymes. By identifying restriction sites in
the expected amplification product, we can predict
which digests will result in shifts in the dissociation
peak. VASRE analysis of the products amplified from
the genes RELA and NFKB2 is shown in Figure 2.
Shifts in the peak of the dissociation curve were
observed only after digestion with enzymes having a
restriction site in the expected product.
Effect of sample complexity on amplification efficiency
While gDNA has the advantage of acting as a source for any
gene target, it also contains a large excess of non-target
sequence. In contrast, plasmids or cDNA standards contain
a relatively small amount of non-target sequence. We postu-
lated that ampliﬁcation efﬁciency may be affected by both
the inherent properties of the primer pair and the complexity
and nature of the DNA sample containing the target to be
ampliﬁed. As gDNA is to be used as an external standard
for the quantiﬁcation of gene expression in cDNA, it is
necessary to ensure that the differences in complexity do
not confound these measurements.
Standard curves were generated by amplifying a dilution
series of plasmid containing the gene for GFP by real-time
PCR and plotting the Ct values against the concentration
of plasmid. To examine the effect of sample complexity
on ampliﬁcation efﬁciency, increasing amounts of gDNA
or cDNA were spiked into the GFP dilution series. The
quantities of gDNA used were identical to quantities we typi-
cally use for generating standard curves (9–0.111 ng), and
the quantities of cDNA represent typical amounts used in
our experiments. The standard curves were assessed for two
properties, the coefﬁcient of correlation (R
2), and the ampli-
ﬁcation efﬁciency (E) determined from the slope of the
standard curve. As shown in Table 1, high-quality standard
curves were produced in the absence or presence of back-
ground DNA (R
2 > 0.989). Furthermore, neither the presence
of background gDNA or cDNA signiﬁcantly affected
ampliﬁcation efﬁciency.
We extended this analysis by assessing GFP ampliﬁcation
in the presence of even higher concentrations of DNA
ranging between 30.8 and 60 ng. GFP ampliﬁcation was
inhibited in the presence of higher gDNA concentrations
(Table 2) whereas cDNA quantities over this range was not
inhibitory (data not shown), suggesting that the bulk amount
of background nucleic acid may not necessarily be the
sole determinant in inhibiting PCR ampliﬁcation and that
the structural nature of the gDNA may also contribute.
Mechanical shearing of gDNA effectively removed much of
the inhibition of GFP ampliﬁcation (Table 2).
Although the range of gDNA that we typically use in our
standard curves does not impair ampliﬁcation from GFP plas-
mid, we also wanted to ensure that ampliﬁcation directly
from the gDNA is not affected by the mechanical shearing
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Figure 2. Verification of Amplicon Specificity using Restriction Enzymes
(VASRE) on two real-time PCR amplicons. Expected digestion patterns are
shown in the panels on the right. Dissociation curves after digestion with
HpyCH4V and RsaI confirm the specificity of two amplicons when compared
to expected results.
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we generated standard curves using sheared or unsheared
gDNA in the range of 9–0.111 ng with eight different primer
pairs. Shearing the DNA affected neither the slope nor the
correlation coefﬁcient for any of the primer pairs tested
(Table 3).
Comparison between external standards
Plasmid DNA is often used as an external standard for abso-
lute quantiﬁcation in real-time PCR. We compared ampliﬁca-
tion from  14.5 fg ( 2574 copies) of plasmid containing the
human PRKR gene to ampliﬁcation from the same target in
9n g(  2574 copies) of gDNA extracted from three different
tissues (HT, Human tonsil; HS, Human subcarinal lymph
node; and HL, Human lung tissue). The Ct score measured
in each sample (n ¼ 12) was not signiﬁcantly different
between the groups (Supplementary Figure A).
HT gDNA was used to construct a standard curve from
which the copy numbers of eight different target genes
were determined in human gDNA from both subcarinal
lymph node and lung. Each genomic sample was assessed
at serial dilutions that covered the range of the standard
curve. At each input level, the number of copies was not sig-
niﬁcantly different for each of the eight targets. Furthermore,
the number of copies determined from each source was in
agreement with each other at each dilution (Supplementary
Figure B).
The three gDNA sources were compared by constructing
standard curves from each and assessing gene expression in
various cDNA samples. The number of copies of the PRKR
target was determined in 10 ng of cDNA from U937 cell
line treated with and without interferon for 4 h and in 1 ng
of cDNA from peripheral CD4
+ and CD8
+ T cells. No signif-
icant differences were seen between the values obtained
from each standard curve (Supplementary Figure C).
Reproducibility of quantification between multiple
primer pairs and the effect of primer sequence position
We have assessed copy numbers using ﬁve different primer
pairs targeting different regions of the PRKR gene
(Figure 3A) in 9 ng of human tonsil, subcarinal lymph node
and lung gDNA. No signiﬁcant differences were observed in
Table 1. Effect of sample complexity on amplification efficiency: standard curves were constructed from a plasmid containing varying copies of the green
fluorescent protein gene. The slope, R
2 value and efficiency of standard curves are shown in the absence of background material and in the presence of increasing
quantities of gDNA or CDNA
BDC Water gDNA cDNA
0 0.111 0.333 1 3 9 1392 7
Slope  3.82  3.39  3.26  3.20  3.56  3.31  3.43  3.48  3.57  3.36
R
2 0.993 0.993 0.989 0.994 0.997 0.992 0.995 0.995 0.995 0.993
Efficiency 83 97 103 105 91 101 96 94 91 98
BDC, background DNA concentration (ng/reaction).
Table2. Effect ofsample complexityon amplification efficiency:GFP plasmidamplification in presenceof varying concentrations of unshearedor shearedgDNA
BDC 0 30.8 38.6 48 60
Unsheared Slope  3.30  1.74  1.41  0.96  0.48
R
2 0.990 0.865 0.660 0.643 0.176
Efficiency 101 275 N/A N/A N/A
Sheared Slope  3.30  2.97  3.17  3.15  2.78
R
2 0.990 0.994 0.986 0.995 0.980
Efficiency 101 117 107 108 129
N/A, not available due to poor correlation between replicates.
Table 3. Effect of sample complexity on amplification efficiency: effect of shearing on amplification of eight target genes
Gene Primer Pair Slope R
2 Efficiency
Unsheared Sheared Unsheared Sheared Unsheared Sheared
HsIFNB1  3.36  3.26 0.978 0.984 99 102
HsTLR3  3.28  3.31 0.985 0.979 102 101
HsIRF7  2.83  3.06 0.925 0.967 125 112
HsSCYA2  3.09  3.35 0.988 0.990 111 99
HsPRKR P2  3.27  3.43 0.993 0.996 102 96
HsOAS2  3.29  3.25 0.994 0.993 102 103
HsIFIT1  3.36  3.36 0.918 0.982 98 99
HsGAPD  3.43  3.42 0.981 0.991 96 96
R
2 indicates the degree of correlation between replicates.
Amplification efficiency (%) ¼ [10
( 1/slope)   1] · 100.
PAGE 5 OF 10 Nucleic Acids Research, 2006, Vol. 34, No. 12 e85the assessed quantity between the three sources of gDNA
regardless of the target position (Figure 3B). In contrast,
the copy number determined in cDNA samples obtained
from the U937 cell line treated with and without interferon
for 4 h or from peripheral CD4
+ and CD8
+ T cells is affected
by the target site (Figure 3C). The assessed quantity of
transcript copy decreases as the target region moves upstream
from the 30 end of the transcript. Primers closest to each other
in the 30-UTR (HsPRKR P4 and HsPRKR P5 in Figure 3A)
are generally in agreement although less so when assessing
expression in interferon treated cells due to the high copy
numbers which exceed the standard curve. In spite of the
difference in copy numbers between each primer pair, the
ratios of target copy numbers between IFN treated and
untreated samples and between CD8+ and CD4+ samples
were comparable for each primer pair (Figure 3D).
This position-dependent effect is likely due to the efﬁ-
ciency of the reverse transcription reaction, which has long
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Figure 3. Effect of target position in assessment of PRKR copy number in gDNA and cDNA. (A) Target regions of five primers in PRKR transcript. (B) Absolute
quantities in 9 ng of three gDNA (HT, human tonsil; HS, human subcarinal lymph node; HL, human lung) assessed using five primer pairs targeting different
regions of the transcript. (C) Absolute quantities in 10 ng of cDNA from IFN treated or untreated U937 human monocytic cell line and 1 ng of cDNA from
human peripheral CD4 and CD8 cells assessed using five primer pairs targeting different regions of the transcript. (D) Ratio of PRKR copy numbers between IFN
treated and untreated U937 cells, and CD8
+ and CD4
+ T cells.
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ing primers near the 30 end to help mitigate this effect. We
examined this further by assessing the transcript copy number
for eight different genes in CD4
+ and CD8
+ T cell cDNA
using two sets of primer pairs designed against the 30 region
of each gene (Figure 4A). The assessed quantity was highly
correlated (R
2 ¼ 0.968) between the two sets of primers
(Figure 4B).
Real-time PCR and microarray
Quantitative real-time PCR is often used to validate the
results obtained from microarray experiments (24–26). We
examined the relative gene expression proﬁles of human
CD4
+ and CD8
+ T cells obtained by microarray analysis
(M. Hyrcza, M. Ostrowski and S. D. Der, unpublished data)
and validated the levels of 43 single-copy genes. Of these, 29
were not different between the two cell types (data not
shown). The remaining 14 were differently expressed on
the microarray and the direction of change for each was con-
ﬁrmed by real-time PCR although the log2 CD8
+/CD4
+ ratios
tended to be higher in real-time PCR than in microarray ana-
lysis (Figure 5A). Nevertheless, the quantities determined by
qPCR were highly correlated (R
2 ¼ 0.981) with the quantities
determined by microarray analysis (Figure 5B).
Mouse genotyping
Other applications that have relied upon real-time PCR are
single nucleotide polymorphism detection and genotyping
(4,13,14). We have applied the gDNA external standard to
genotype human-tau transgenic mice using real-time PCR.
Mouse-tail gDNA samples were isolated from the F2 genera-
tion of a homozygous/null cross. Expected ratios were 1/2
heterozygous, 1/4 homozygous and 1/4 null. The gDNA
was ampliﬁed with two human-tau speciﬁc primer pairs as
well as two primer pairs for internal reference genes
(GRO1 and IL6). Human tonsil gDNA was used as an exter-
nal standard to measure human-tau gene, and mouse liver
gDNA was used to quantify the internal reference genes.
The quantity of each gene obtained by real-time PCR was
normalized with the internal reference genes to account for
multiple insertions. A clear distinction is evident between
the three populations with 12/20 heterozygous, 4/20 homo-
zygous and 4/20 null (Figure 6). Multiple transgene copies
of the inserted gene are also indicated, three to four copies
in the haploid genome.
DISCUSSION
Quantitative real-time PCR is a well-proven and valuable tool
for assessing gene expression. When determining the change
in expression of a particular gene in response to a speciﬁc
treatment or the difference in expression between two sam-
ples, ampliﬁcation of an internal control or reference gene
that is assumed to be constant between samples is generally
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Figure 5. Validation of microarray data using real-time PCR with a gDNA
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+ T cells
as assessed by real-time PCR (closed) or Affymetrix Microarray (open).
(B) Comparison of Log2 Ratios for each gene. The slope of the regression line
(R
2 ¼ 0.981) is 0.59 indicating that microarray values are  60% of those seen
by real-time PCR.
                                                               
Figure 4. Assessment of gene transcript copy number using different real-
time PCR targets. Expression level of eight genes was determined in CD4
+
(open) and CD8
+ (closed) T cells by amplification of two target sites in each
gene. Absolute quantity was assessed in 1 ng of cDNA from each type of
T cell. (A) The graph shows the quantity determined with each primer pair
(P1 versus P2). (B) The correlation (0.968) between Log2 Ratio (CD8
+/CD4
+)
for the two sets of primers is shown.
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changes in gene expression is often sufﬁcient for most experi-
mental purposes, the importance of determining the absolute
copy number for an expressed sequence can be highlighted in
cases where the degree of fold change may over- or under-
signify the biological phenomena. For example, an increase
from 10 to 100 copies (10-fold change) may carry less bio-
logical signiﬁcance compared to an increase from 1000 to
5000 copies (5-fold change) even though in relative terms
the former appears to have a greater induction. Furthermore,
with relative quantiﬁcation it is difﬁcult to compare gene
expression levels between studies that do not use the same
baseline control, or where the baseline may not be constant.
Determination of absolute copy numbers removes the need
for a common baseline. This is particularly useful in pathogen
load diagnosis (7–9) and cancer marker detection (10–12), in
which normal controls are often different between studies.
Using real-time PCR to determine absolute copy number
requires that a series of standards of known quantity be
assessed in the same assay. The Ct values obtained from
these standards can be used to generate a standard curve
from which the quantity of unknown samples can be calcu-
lated. There is an absolute requirement that each standard
contains the same target region that is ampliﬁed in the
sample. In our laboratory, tissue gDNA is used as an external
standard for calculation of copy numbers in unknown
samples. There are several advantages to using gDNA over
other materials such as plasmid DNA, puriﬁed PCR products
or reverse-transcribed cRNA. First, the heterogeneous nature
of a cDNA population is better represented by gDNA as opp-
osed to the more homogenous pools found in these other
materials. Second, the quantity of plasmid DNA neces-
sary to achieve a useable copy number is generally in the
femtogram range. Puriﬁed PCR product and reverse-
transcribed cRNA require similar quantities. For example,
1 ng of plasmid DNA contains  100 million copies of target
sequence (1.9 · 10
8 copies of GFP plasmid and 1.2 · 10
8
copies of PRKR plasmid). After dilution to concentrations
at the lower range of spectrophotometric detection, genera-
tion of external standards would still require multiple-
step dilutions to achieve copy numbers approaching
those expected in expressed sequences. This presents an
opportunity for the introduction of small errors at each step
to be ampliﬁed to signiﬁcant variation in standard quantity.
Furthermore, dilution of DNA to such low concentrations is
not suitable for long-term storage. The addition of carrier
nucleic acids to plasmid DNA may improve its long-term sto-
rage, but not solve the problem of multiple-step dilutions.
Lastly, the same gDNA pool can be used as an external stan-
dard for the ampliﬁcation of any gene product as it contains a
copy of all genes. The other external standards require unique
pools that have to be designed and constructed for each gene
of interest, a time-consuming process that can also be very
costly for large-scale experiments.
Our results show that PCR efﬁciency is affected by the
complexity of the material from which a target is ampliﬁed.
This includes both the quantity as well as the composition of
background DNA. Real-time PCR is inhibited at high back-
ground gDNA concentrations and/or in the presence of long
strands of structurally complex DNA. While these inhibitory
effects do not appear at the gDNA concentrations that are
typically used to generate standard curves in our laboratory,
it can affect quantiﬁcation when using higher concentrations
of gDNA standards or when assessing copy numbers in
unknown gDNA samples. In such circumstances, the inhibi-
tory effects can be overcome by moderate shearing of
gDNA, which removes some of this complexity. We have
additionally demonstrated that shearing of gDNA does not
adversely affect the target ampliﬁcation within the gDNA
due to the potential loss of target sites.
gDNA can be extracted easily from a variety of sources,
and it is expected that ampliﬁcation of a target sequence
with a given primer pair should be equally efﬁcient regardless
of this source. The standard curves constructed from the
ampliﬁcation of a target region in the PRKR gene from
three gDNA preparations (tonsil, subcarinal lymph node
and lung) or within a plasmid did not differ signiﬁcantly in
quality or in efﬁciency of ampliﬁcation. Furthermore, the
quantity of PRKR transcript assessed in various cDNA sam-
ples was the same regardless of the gDNA source used to
construct a standard curve. The equivalency of these three
gDNA standards was further veriﬁed by ampliﬁcation with
primers for a number of randomly selected genes.
We have highlighted in this paper the importance of
choosing an optimal target region to assess gene expression.
Consistent quantiﬁcation was observed between ampliﬁcation
from target regions that were located in similar regions of
a gene. Generally, the assessed copy number determined
from targets in the 50 region of the gene was lower than
that determined from targets in the 30 region. This is likely
due to inefﬁcient reverse transcription reaction resulting in
incomplete cDNA representation of the 50 ends of the tran-
scripts. Assessment of copy number was not affected by the
primers’ target location in gDNA. In general, when amplify-
ing from cDNA, it is therefore preferable to target the 30-UTR
to minimize underestimation of the transcript copy number.
In our laboratory, real-time PCR is used to verify changes
in gene expression observed with DNA microarrays. This is
the ﬁrst step to eliminate false positives prior to pursuing
further analysis on the functional characterization of identi-
ﬁed genes. We have shown in this paper that the real-time
PCR using a gDNA standard is effective at verifying the
differences in gene expression between two different human
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Figure 6. Genotyping of human-tau transgenic mice using mouse-tail gDNA
as standard for real-time PCR. Null and homo indicate the expected ratio
between absolute quantity of transgene and of internal reference gene in null
(tau  / ) and homozygous (tau +/+) transgenic mice.
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+ and CD8
+). The need for a higher degree
of accuracy for assessing global gene expression with
high-throughput platforms is increasing, and the ability to
determine absolute copy numbers with real-time PCR will
play a crucial role in validating the design of these platforms
and the algorithms used for their analysis. Real-time PCR is
also a valuable tool for other applications beyond assessing
gene expression such as assessment of copy number in trans-
genic mice. We have shown that a litter of mice could effec-
tively be classiﬁed into null, heterozygous and homozygous
groups for the gene in question.
The use of any external standard does not preclude the
need for appropriate internal references, which monitor
aspects of sample preparation such as RNA isolation and
RT efﬁciency. While we believe that the relatively simple
approach described in our study for quantiﬁcation of gene tar-
gets in cDNA samples provides a richer form of data than
relative quantiﬁcation, there has not yet been methodologies
described for achieving absolute quantiﬁcation of transcript
copies in live cells or tissues that have been robustly tested
and universally accepted. Simultaneous quantiﬁcation of an
internal reference can be used to further adjust measured tar-
get quantities that are independent of the speciﬁc experimen-
tal procedure. An effective combination of both external
standard and internal reference provides the best means by
which to most accurately quantify gene expression. Further-
more, intra-assay variability has long been an issue for micro-
array studies, and is being addressed by development of a set
of universal RNA reference materials (27). Adoption of simi-
lar reference material for qPCR studies could further contri-
bute toward standardization of gene expression data
especially when comparing real-time PCR data to that
obtained from microarray analysis.
In summary, there are many advantages to using gDNA as
an external standard for quantitative real-time PCR. This
includes the structural similarity of sheared gDNA to
cDNA, the ability to use preparations of gDNA without
excessive dilution, and the greater stability of these more con-
centrated solutions during long-term storage. Although there
has been an effort to construct a DNA external standard con-
taining multiple target sequences for several primer pairs
(23), gDNA is a truly universal external standard applicable
to all endogenous genes in the genome. The cost, time and
effort required for the preparation of gDNA are minimal com-
pared to those for construction of external standards using
puriﬁed plasmid or cDNA, which contain a unique target
sequence. With all these advantages, we anticipate that the
use of gDNA as external standard will contribute signiﬁcantly
to the accurate quantiﬁcation of copy number using quantita-
tive real-time PCR.
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